Ryan Specialty (NYSE:RYAN) Price Target Cut to $59.00 by Analysts at UBS Group

Ryan Specialty (NYSE:RYAN) had its target price lowered by analysts at UBS Group from $65.00 to $59.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group’s price target would suggest a potential upside of 69.04% from the stock’s current price.

RYAN has been the subject of a number of other reports. JPMorgan Chase & Co. lowered their price objective on Ryan Specialty from $63.00 to $56.00 and set an “underweight” rating for the company in a research note on Wednesday, January 7th. Royal Bank Of Canada initiated coverage on Ryan Specialty in a research note on Tuesday, March 17th. They set an “outperform” rating and a $45.00 price objective for the company. Cantor Fitzgerald lowered their price objective on Ryan Specialty from $52.00 to $45.00 and set a “neutral” rating for the company in a research note on Tuesday, February 17th. Citigroup lowered their price objective on Ryan Specialty from $60.00 to $55.00 and set a “buy” rating for the company in a research note on Monday, March 23rd. Finally, BMO Capital Markets downgraded Ryan Specialty from an “outperform” rating to a “market perform” rating and lowered their price objective for the stock from $66.00 to $43.00 in a research note on Wednesday, February 25th. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, five have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $52.44.

Ryan Specialty Stock Performance

Shares of NYSE RYAN traded up $1.26 during trading on Wednesday, reaching $34.90. The stock had a trading volume of 2,205,856 shares, compared to its average volume of 2,091,714. Ryan Specialty has a one year low of $31.50 and a one year high of $75.26. The company has a debt-to-equity ratio of 2.62, a quick ratio of 0.98 and a current ratio of 0.98. The stock has a market cap of $9.22 billion, a PE ratio of 83.10, a P/E/G ratio of 0.88 and a beta of 0.71. The firm’s 50 day moving average price is $38.98 and its two-hundred day moving average price is $48.73.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings results on Thursday, February 12th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). The firm had revenue of $751.21 million during the quarter, compared to the consensus estimate of $777.43 million. Ryan Specialty had a net margin of 7.02% and a return on equity of 46.41%. Ryan Specialty’s revenue was up 13.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.45 earnings per share. On average, research analysts forecast that Ryan Specialty will post 2.29 earnings per share for the current fiscal year.

Insider Activity at Ryan Specialty

In other Ryan Specialty news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the company’s stock in a transaction that occurred on Monday, February 23rd. The shares were purchased at an average cost of $39.96 per share, with a total value of $1,018,980.00. Following the completion of the transaction, the director owned 428,295 shares of the company’s stock, valued at approximately $17,114,668.20. This represents a 6.33% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 52.03% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Ameritas Investment Partners Inc. increased its position in Ryan Specialty by 0.9% in the 3rd quarter. Ameritas Investment Partners Inc. now owns 21,119 shares of the company’s stock worth $1,190,000 after purchasing an additional 185 shares during the last quarter. Baker Tilly Wealth Management LLC increased its position in Ryan Specialty by 5.6% in the 3rd quarter. Baker Tilly Wealth Management LLC now owns 3,595 shares of the company’s stock worth $203,000 after purchasing an additional 192 shares during the last quarter. Public Employees Retirement System of Ohio increased its position in Ryan Specialty by 0.6% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 32,797 shares of the company’s stock worth $1,848,000 after purchasing an additional 203 shares during the last quarter. Covestor Ltd increased its position in Ryan Specialty by 16.8% in the 4th quarter. Covestor Ltd now owns 1,467 shares of the company’s stock worth $76,000 after purchasing an additional 211 shares during the last quarter. Finally, Northwestern Mutual Investment Management Company LLC increased its position in Ryan Specialty by 1.0% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 25,355 shares of the company’s stock worth $1,309,000 after purchasing an additional 240 shares during the last quarter. 84.82% of the stock is owned by institutional investors and hedge funds.

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.